BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11774471)

  • 1. Involvement in fusion activity of an epitope in the S2 subunit of murine coronavirus spike protein.
    Taguchi F; Shimazaki YK
    Adv Exp Med Biol; 2001; 494():213-8. PubMed ID: 11774471
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity.
    Taguchi F; Shimazaki YK
    J Gen Virol; 2000 Dec; 81(Pt 12):2867-2871. PubMed ID: 11086117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amino acid insertions in the cysteine-rich domain of the MHV-A59 spike protein on cell fusion.
    Chang KW; Gombold JL
    Adv Exp Med Biol; 2001; 494():205-11. PubMed ID: 11774470
    [No Abstract]   [Full Text] [Related]  

  • 5. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.
    Kuo L; Godeke GJ; Raamsman MJ; Masters PS; Rottier PJ
    J Virol; 2000 Feb; 74(3):1393-406. PubMed ID: 10627550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor specificity and receptor-induced conformational changes in mouse hepatitis virus spike glycoprotein.
    Holmes KV; Zelus BD; Schickli JH; Weiss SR
    Adv Exp Med Biol; 2001; 494():173-81. PubMed ID: 11774465
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro properties and pathogenesis of A59/MHV4 chimeric mouse hepatitis viruses.
    Tsai JC; Weiss SR
    Adv Exp Med Biol; 2001; 494():169-72. PubMed ID: 11774464
    [No Abstract]   [Full Text] [Related]  

  • 8. Single amino acid changes in the S2 subunit of the MHV surface glycoprotein confer resistance to neutralization by S1 subunit-specific monoclonal antibody.
    Grosse B; Siddell SG
    Virology; 1994 Aug; 202(2):814-24. PubMed ID: 8030244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion.
    Krueger DK; Kelly SM; Lewicki DN; Ruffolo R; Gallagher TM
    J Virol; 2001 Mar; 75(6):2792-802. PubMed ID: 11222703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor.
    Matsuyama S; Taguchi F
    Virology; 2002 Mar; 295(1):160-71. PubMed ID: 12033774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity.
    Bos EC; Luytjes W; Spaan WJ
    J Virol; 1997 Dec; 71(12):9427-33. PubMed ID: 9371603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein.
    Navas-Martin S; Hingley ST; Weiss SR
    J Virol; 2005 Jun; 79(12):7629-40. PubMed ID: 15919915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.
    Miura HS; Nakagaki K; Taguchi F
    J Virol; 2004 Jan; 78(1):216-23. PubMed ID: 14671103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus-induced membrane fusion requires the cysteine-rich domain in the spike protein.
    Chang KW; Sheng Y; Gombold JL
    Virology; 2000 Mar; 269(1):212-24. PubMed ID: 10725213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-induced conformational changes of murine coronavirus spike protein.
    Matsuyama S; Taguchi F
    J Virol; 2002 Dec; 76(23):11819-26. PubMed ID: 12414924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of the immunodominant CD8+ epitope in the MHV-4 spike protein.
    Chua MM; Phillips JJ; Seo SH; Lavi E; Weiss SR
    Adv Exp Med Biol; 2001; 494():121-5. PubMed ID: 11774455
    [No Abstract]   [Full Text] [Related]  

  • 17. Inefficient infection of soluble receptor-resistant mutants of murine coronavirus in cells expressing MHVR2 receptor.
    Matsuyama S; Taguchi F
    Adv Exp Med Biol; 2001; 494():233-6. PubMed ID: 11774474
    [No Abstract]   [Full Text] [Related]  

  • 18. A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.
    Yoo D; Deregt D
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):297-302. PubMed ID: 11238212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.
    Li F; Li W; Farzan M; Harrison SC
    Science; 2005 Sep; 309(5742):1864-8. PubMed ID: 16166518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitutions of conserved amino acids in the receptor-binding domain of the spike glycoprotein affect utilization of murine CEACAM1a by the murine coronavirus MHV-A59.
    Thackray LB; Turner BC; Holmes KV
    Virology; 2005 Mar; 334(1):98-110. PubMed ID: 15749126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.